Brigham Young University researchers have developed a promising cancer treatment by programming macrophages—white blood cells—to attack tumors, the Salt Lake Tribune reports. The breakthrough could offer a new immunotherapy approach with fewer side effects than current treatments.

The research team published findings showing the reprogrammed cells successfully targeted cancer in laboratory tests. BYU is now seeking partnerships to advance the therapy toward clinical trials. The university's life sciences program has grown its research profile in recent years with federal and private funding.